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Introduction
Plasma NT-PRO-BNP is a known diagnostic and prognos-
tic heart failure biomarker, correlate with ventricular wall
stress and severity of heart failure.
Objectives
To assess whether plasma NT-PRO-BNPs kinetic could
predict postoperative early outcome of CS [1].
Methods
A prospective, descriptive study for 4 months (period:
Oct 2014 - Jan 2015) in patients (pts.) admitted to our
ICU. We included adults undergoing emergent, elective
or semi-urgent heart valve replacement, coronary artery
bypass grafting, and aortic aneurysm surgery. The pts.
with chronic diseases that can increase the baseline
NT-PRO-BNP level like chronic kidney disease, peripheral
vascular disease, and chronic pulmonary disease, were
excluded. Data, including perioperative and outcome data,
were collected daily for 5 days. The postoperative compli-
cations were reflected by inotropic and vasoactive drugs
used, postoperative acute renal failure, and mechanical
ventilation time longer than 24 hours. The results were
reported as median (interquartile range).
Results
A total of 37 pts. (75,7% males), of 84 pts. admitted to ICU
for postoperative care after CS, were included. Mean age
was 65 ± 12 years. APACHE II on ICU admission was
26 ± 3. Mean ICU stay was 3 ± 1,6 days. NT-PRO-BNP
concentration increased from 703 (5,3-3403) preopera-
tively to peak level of 1731 pg/ml (276-6674), reached at
48 hours postoperatively. Serum NT-PRO-BNP peak value
in complicated vs. non-complicated CS was 1847 (50,2-
6674) vs. 1372 (960-1965) pg/ml (p = 0,003). Pts. who
developed postoperative acute renal failure (n = 12) had
preoperative NT-PRO-BNP of 1132 (33,5-3403), vs. 496
(5,3-3263) pg/ml registered in pts. with preserved renal
function (p = 0,005). Preoperative serum NT-PRO-BNP in
pts. who needed for inotropic and vasoactive suport
(n = 23) was 867 (5,3-3400), vs. 432 (33,5-1191) pg/ml in
pts. who did not require perioperative inotropic and
vasoactive medication (p = 0,003). No correlation between
time of mechanical ventilation, ICU lenght of stay, and
preoperative NT-PRO-BNP level were founded. Decreased
preoperative left ventricular ejection fraction was detected
in 29,7% pts. In those cases we founded postoperative
serum NT-PRO-BNP peak level of 3034 (747-7550), vs.
1394 (154-4454) pg/ml in pts. with preserved preoperative
ventricular function (p = 0,001).
Conclusions
Preoperative NT-PRO-BNP is a valuable marker in pre-
dicting early postoperative outcomes after CS. High
preoperative NT-PRO-BNP levels were associated with
the need for inotropic and vasoactive support, and the
deterioration of renal function in the early postopera-
tive period. The peak levels, reached at 48 hours post-
operatively, correlated with preoperative ejection
fraction.
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